Literature DB >> 10882673

Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay.

T Messele1, M T Roos, D Hamann, M Koot, A L Fontanet, F Miedema, P T Schellekens, T F Rinke de Wit.   

Abstract

T-cell proliferation is an important in vitro parameter of in vivo immune function and has been used as a prognostic marker of human immunodeficiency virus type 1 (HIV-1) disease progression. The proliferative capacity of T cells in response to various stimuli is commonly determined by a radioactive assay based on incorporation of [(3)H]thymidine ([(3)H]TdR) into newly generated DNA. In order to assess techniques for application in laboratories where radioactive facilities are not present, two alternative methods were tested and compared to the [(3)H]TdR assay as a "gold standard." As an alternative, T-cell proliferation was measured by flow cytometric assessment of CD38 expression on T cells and by an enzyme-linked immunosorbent assay (ELISA) based on bromo-2'-deoxyuridine (BrdU) incorporation. Peripheral blood mononuclear cells (PBMCs), either in whole blood or Ficoll-Isopaque separated, from a total of 26 HIV-1-positive and 18 HIV-1-negative Dutch individuals were stimulated with CD3 monoclonal antibody (MAb) alone, a combination of CD3 and CD28 MAbs, or phytohemagglutinin. BrdU incorporation after 3 days of stimulation with a combination of CD3 and CD28 MAbs correlated excellently with the [(3)H]TdR incorporation in both study groups (HIV-1 positives, r = 0.96; HIV-1 negatives, r = 0.83). A significant correlation of absolute numbers of T cells expressing CD38 with [(3)H]TdR incorporation, both in HIV-1-positive (r = 0.96) and HIV-1-negative (r = 0.84) individuals, was also observed under these conditions. The results of this study indicate that determination of both the number of CD38-positive T cells and BrdU incorporation can be used as alternative techniques to measure the in vitro T-cell proliferative capacity. The measurement of CD38 expression on T cells provides the additional possibility to further characterize the proliferating T-cell subsets for expression of other surface markers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882673      PMCID: PMC95935          DOI: 10.1128/CDLI.7.4.687-692.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  34 in total

1.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.

Authors:  T Messele; M Abdulkadir; A L Fontanet; B Petros; D Hamann; M Koot; M T Roos; P T Schellekens; F Miedema; T F Rinke de Wit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy.

Authors:  J J Ballet; L J Couderc; C Rabian-Herzog; C Duval-Roy; M Janier; F Danon; J P Clauvel; M Seligmann
Journal:  AIDS       Date:  1988-08       Impact factor: 4.177

3.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

Authors:  H C Lane; J M Depper; W C Greene; G Whalen; T A Waldmann; A S Fauci
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

4.  Kinetics of activation antigen expression by in vitro-stimulated human T lymphocytes.

Authors:  W Holter; O Majdic; K Liszka; H Stockinger; W Knapp
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

5.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

Authors:  B F Polk; R Fox; R Brookmeyer; S Kanchanaraksa; R Kaslow; B Visscher; C Rinaldo; J Phair
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

6.  Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. Accessory cell-independent induction of interleukin 2 responsiveness in T cells by epsilon-anti-CD3.

Authors:  R A van Lier; J H Boot; A J Verhoeven; E R de Groot; M Brouwer; L A Aarden
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

7.  Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.

Authors:  F de Wolf; J M Lange; J T Houweling; R A Coutinho; P T Schellekens; J van der Noordaa; J Goudsmit
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

8.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).

Authors:  G M Shearer; D C Bernstein; K S Tung; C S Via; R Redfield; S Z Salahuddin; R C Gallo
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

10.  Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies.

Authors:  R A Van Lier; M Brouwer; L A Aarden
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

View more
  10 in total

1.  Evaluation of adenosine deaminase assay for analyzing T-lymphocyte density in vitro.

Authors:  Rani Poonam Kainthla; Rajpal Singh Kashyap; Sweta Prasad; Hemant J Purohit; Giridhar M Taori; Hatim F Daginawala
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Nov-Dec       Impact factor: 2.416

Review 2.  In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.

Authors:  Anne M Goodwin
Journal:  Microvasc Res       Date:  2007-06-06       Impact factor: 3.514

3.  Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome.

Authors:  H Zheng; C Ye; M Segura; M Gottschalk; J Xu
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

4.  Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus.

Authors:  R C Howe; N Dhiman; I G Ovsyannikova; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

5.  Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.

Authors:  Imad Al Ghouleh; Sanghamitra Sahoo; Daniel N Meijles; Jefferson H Amaral; Daniel S de Jesus; John Sembrat; Mauricio Rojas; Dmitry A Goncharov; Elena A Goncharova; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2017-07-16       Impact factor: 6.124

6.  Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells.

Authors:  Sivan Cohen; Srividya Myneni; Anna Batt; Joyce Guerrero; Jochen Brumm; Shan Chung
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

7.  Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs.

Authors:  Jennifer N Gibson; Pavani Beesetty; Courtney Sulentic; J Ashot Kozak
Journal:  J Vis Exp       Date:  2016-12-27       Impact factor: 1.355

Review 8.  A Critical Analysis of the Available In Vitro and Ex Vivo Methods to Study Retinal Angiogenesis.

Authors:  A F Moleiro; G Conceição; A F Leite-Moreira; A Rocha-Sousa
Journal:  J Ophthalmol       Date:  2017-08-07       Impact factor: 1.909

Review 9.  Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.

Authors:  Anja Saso; Beate Kampmann; Sophie Roetynck
Journal:  Vaccines (Basel)       Date:  2021-08-07

Review 10.  The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.

Authors:  Yorick Janssens; Jasper Joye; Gwenn Waerlop; Frédéric Clement; Geert Leroux-Roels; Isabel Leroux-Roels
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.